Mycobacterium tuberculosis cell wall released fragments by the action of the human lung mucosa modulate macrophages to control infection in an IL-10-dependent manner

Mucosal Immunology

Volumn 10, Issue 5, 2017, Pages 1248-1258

  Arcos, J ^a   Sasindran, S J ^a   Moliva, J I ^a   Scordo, J M ^a   Sidiki, S ^a   Guo, H ^a   Venigalla, P ^a   Kelley, H V ^a   Lin, G ^a   Diangelo, L ^a   Silwani, S N ^a   Zhang, J ^a,b   Turner, J ^a,b   Torrelles, J B ^a,b  

^a Department of Microbial Infection and Immunity ^*  (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN;

ACIDIFICATION; ARTICLE; BACTERIAL CELL WALL; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPOSURE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; INFECTION CONTROL; LUNG MUCOSA; LYSOSOME; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHAGOSOME; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; CELL CULTURE; CELL WALL; IMMUNOLOGY; INNATE IMMUNITY; LUNG TUBERCULOSIS; MEMBRANE FUSION; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHAGOCYTOSIS; RESPIRATORY MUCOSA;

CELL WALL; CELLS, CULTURED; HUMANS; HYDROLASES; IMMUNITY, INNATE; INTERLEUKIN-10; LYSOSOMES; MACROPHAGES; MEMBRANE FUSION; MYCOBACTERIUM TUBERCULOSIS; PHAGOCYTOSIS; PHAGOSOMES; RESPIRATORY MUCOSA; STAT3 TRANSCRIPTION FACTOR; TUBERCULOSIS, PULMONARY;

EID: 85022041709     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2016.115     Document Type: Article

References (46)

1. WHO. WHO Tuberculosis Fact Sheet 2015. World Health Organization 15A.D. 20 March. Available from: URLhttp://www.who.int/mediacentre/ factsheets/fs104/en/.
2. Torrelles, J.B. Broadening our view about the role of Mycobacterium tuberculosis cell envelope components during infection: a battle for survival. In Understanding Tuberculosis - Analyzing the Origin of Mycobacterium tuberculosis Pathogenicity (Cardona, PJ, ed) 77-122 (Intech, Rijeka, Croatia, 2012).
3. Arcos, J., Sasindran, S.J., Fujiwara, N., Turner, J., Schlesinger, L.S. & Torrelles, J.B. Human lung hydrolases delineate Mycobacterium tubercu-losis-macrophage interactions and the capacity to control infection. J. Immunol. 187, 372-381 (2011).
4. Schlesinger, L.S. Phagocytosis and Toll-like receptors in tuberculosis. In Tuberculosis, 2nd edn (Rom, W.N.&Garay, S.M., eds) 203-214 (Lippincott Williams & Wilkins: New York, NY, 2004).
5. Sasindran, J. & Torrelles, J.B. Mycobacterium tuberculosis infection and inflammation: what is beneficial for the host and for the bacterium?. Front. Microbiol. 2, 1-16 (2011).
6. Guirado, E. & Schlesinger, L.S. Modeling the Mycobacterium tuberculosis Granuloma - the Critical Battlefield in Host Immunity and Disease. Front. Immunol. 4, 98 (2013).
7. Helke, K.L., Mankowski, J.L.&Manabe, Y.C. Animal models ofcavitation in pulmonary tuberculosis. Tuberculosis (Edinb) 86, 337-348 (2006).
8. Hawgood, S. & Poulain, F.R. The pulmonary collectins and surfactant metabolism. Annu. Rev. Physiol. 63, 495-519 (2001).
9. Mason, R.J. Biology of alveolar type II cells. Respirology 11 (Suppl), S12-S15 (2006).
10. Kang, P.B. et al. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J. Exp. Med. 202, 987-999 (2005).
11. Axelrod, S. et al. Delay ofphagosome maturationby amycobacterial lipid is reversed by nitric oxide. Cell Microbiol. 10, 1530-1545 (2008).
12. Kastelein, R.A., Hunter, C.A. & Cua, D.J. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu. Rev. Immunol. 25, 221-242 (2007).
13. O'Leary, S., O'Sullivan, M.P. & Keane, J. IL-10 blocks phagosome maturationin Mycobacterium tuberculosis-infected human macrophages. Am. J. Respir. Cell Mol. Biol. 45, 172-180 (2010).
14. Yang, C.S., Yuk, J.M. & Jo, E.K. The role of nitric oxide in mycobacterial infections. Immune Netw. 9, 46-52 (2009).
15. Torrelles, J.B. & Schlesinger, L.S. Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host. Tuberculosis (Edinb) 90, 84-93 (2010).
16. Redford, P.S., Murray, P.J. & O'Garra, A. The role of IL-10 in immune regulation during M. tuberculosis infection. Mucosal Immunol. 4, 261-270 (2011).
17. Gazzinelli, R.T. et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4 + Tcells and accompaniedbyoverproductionofIL-12, IFN-gamma and TNF-alpha. J. Immunol. 157, 798-805 (1996).
18. Hunter, C.A. et al. IL-10 is required to prevent immune hyperactivity during infection with Trypanosomacruzi. J. Immunol. 158, 3311-3316 (1997).
19. Li, C., Corraliza, I. & Langhorne, J. A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice. Infect. Immun. 67, 4435-4442 (1999).
20. Jung, J.Y. & Robinson, C.M. IL-12 and IL-27 regulate the phagolysosomal pathway in mycobacteria-infected human macrophages. Cell Commun. Signal. 12, 16 (2014).
21. Liu, F.D. et al. Timed action of IL-27 protects from immunopathology while preserving defense in influenza. PLoS Pathog. 10, e1004110 (2014).
22. Mosser, D.M. The many faces of macrophage activation. J. Leukoc. Biol. 73, 209-212 (2003).
23. Retini, C., Kozel, T.R., Pietrella, D., Monari, C., Bistoni, F. & Vecchiarelli, A. Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans. Infect. Immun. 69, 6064-6073 (2001).
24. Saraiva, M. & O'Garra, A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10, 170-181 (2010).
25. Day, J., Friedman, A. & Schlesinger, L.S. Modeling the immune rheostat of macrophages in the lung in response to infection. Proc. Natl Acad. Sci. USA 106, 11246-11251 (2009).
26. Martinez, F.O. & Gordon, S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 6, 13 (2014).
27. Flores-Villanueva, P.O. et al. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J. Exp. Med. 202, 1649-1658 (2005).
28. Shanmugham, L.N. et al. Rantes potentiates human macrophage aggregation and activation responses to calcium ionophore (A23187) and activates arachidonic acid pathways. J. Biol. Regul. Homeost. Agents 20, 15-23 (2006).
29. Vesosky, B., Rottinghaus, E.K., Stromberg, P., Turner, J. & Beamer, G. CCL5 participates in early protection against Mycobacterium tuberculosis. J. Leukoc. Biol. 87, 1153-1165 (2010).
30. Castellani, M.L. et al. Expression and secretion of RANTES (CCL5) in granulomatous calcified tissue before and after lipopolysaccharide treatment in vivo. Calcif. Tissue Int. 80, 60-67 (2007).
31. Ma, X. et al. Inhibition of IL-12 production in human monocyte-derived macrophages by TNF. J. Immunol. 164, 1722-1729 (2000).
32. Harris, J., Hope, J.C. & Keane, J. Tumor necrosis factor blockers influence macrophage responses to Mycobacterium tuberculosis. J. Infect. Dis. 198, 1842-1850 (2008).
33. Qualls, J.E. et al. Arginine usage in mycobacteria-infected macrophages depends on autocrine-paracrine cytokine signaling. Sci. Signal. 3, ra62 (2010).
34. Via, L.E., Fratti, R.A., McFalone, M., Pagan-Ramos, E., Deretic, D. & Deretic, V. Effects of cytokines on mycobacterial phagosome maturation. J. Cell Sci. 111, 897-905 (1998).
35. Cyktor, J.C.& Turner,J.Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens. Infect. Immun. 79, 2964-2973 (2011).
36. Lang, R., Rutschman, R.L., Greaves, D.R. & Murray, P.J. Autocrine deactivation of macrophages in transgenic mice constitutively over-expressing IL-10 under control of the human CD68 promoter. J. Immunol. 168, 3402-3411 (2002).
37. Stone, K.C., Mercer, R.R., Gehr, P., Stockstill, B. & Crapo, J.D. Allometric relationships of cell numbers and size in the mammalian lung. Am. J. Respir. Cell Mol. Biol. 6, 235-243 (1992).
38. Stone, K.C., Mercer, R.R., Freeman, B.A., Chang, L.Y. & Crapo, J.D. Distribution of lung cell numbers and volumes between alveolar and nonalveolar tissue. Am. Rev. Respir. Dis. 146, 454-456 (1992).
39. Chroneos, Z.C., Midde, K., Sever-Chroneos, Z. & Jagannath, C. Pulmonary surfactant and tuberculosis. Tuberculosis (Edinb) 89 (Suppl 1), S10-S14 (2009).
40. Torrelles, J.B. et al. Truncated structural variants of lipoarabinomannan in Mycobacterium leprae and an ethambutol-resistant strain of Mycobacter-ium tuberculosis. J. Biol. Chem. 279, 41227-41239 (2004).
41. Schlesinger, L.S. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J. Immunol. 150, 2920-2930 (1993).
42. Arcos, J. et al. Lung mucosa lining fluid modifies Mycobacterium tuberculosis to reprogram human neutrophil killing mechanisms. J. Infect. Dis. 212, 948-958 (2015).
43. Olakanmi, O., Britigan, B.E. & Schlesinger, L.S. Gallium disrupts iron metabolism of mycobacteria residing within human macrophages. Infect. Immun. 68, 5619-5627 (2000).
44. Xiao, Y. et al. Targeting CBLB as a potential therapeutic approach for disseminated candidiasis. Nat. Med. 22, 906-914 (2016).
45. Mohapatra, N.P. et al. Francisella acid phosphatases inactivate the NADPH oxidase in human phagocytes. J. Immunol. 184, 5141-5150 (2010).
46. Rajaram, M.V. et al. Mycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125b. Proc. Natl Acad. Sci. USA 108, 17408-17413 (2011).